Author

Chris Probert

EFFICACY AND SAFETY OF ELECTIVE SWITCHING OF INFLAMMATORY BOWEL DISEASE PATIENTS FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB: A MULTI-CENTRE COHORT STUDY
EFFICACY AND SAFETY OF ELECTIVE SWITCHING OF INFLAMMATORY BOWEL DISEASE PATIENTS FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB: A MULTI-CENTRE COHORT STUDY

Chris Probert  et al.

Item 1 - 1 / 1
1